Tivozanib As Maintenance Therapy In GYN

NCT01972516 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped due to slow accrual

Conditions

Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Carcinoma

Interventions

DRUG: Tivozanib

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]